 | Up a level |
Ghasempour, Ghasem; Zamani-Garmsiri, Fahimeh; Farhad, Shaikhnia; Soleimani, Ali; Hosseini Fard, Syed Reza; Leila, Janani; Teimuri, Shohreh; Parvaz, Najmeh; Mohammadi, Payam; Najafi, Mohammad (2024). Efficacy and Safety of Alirocumab and Evolocumab as Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis. Current medicinal chemistry, 31(2), pp. 223-241. Bentham 10.2174/0929867330666230228120601
